Safety Profile of Evobrutinib in Patients With MS, Rheumatoid Arthritis, or Systemic Lupus Erythematosus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis
J. Neurol. Neurosurg. Psychiatr. 2023 Jan 01;94(1)1-9, X Montalban, D Wallace, MC Genovese, D Tomic, D Parsons-Rich, C Le Bolay, AH Kao, H GuehringFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.